**Core Concept**
Pneumococcal meningitis is a severe infection caused by the bacterium Streptococcus pneumoniae that affects the meninges, the protective membranes surrounding the brain and spinal cord. The empirical treatment of pneumococcal meningitis involves administering antibiotics that are effective against this pathogen.

**Why the Correct Answer is Right**
The first-line empirical treatment for pneumococcal meningitis is vancomycin, often combined with ceftriaxone or cefotaxime, a third-generation cephalosporin. Vancomycin is a glycopeptide antibiotic that acts by inhibiting cell wall synthesis in bacteria. It is particularly effective against penicillin-resistant S. pneumoniae. The combination of vancomycin and a cephalosporin provides broad-spectrum coverage, including against penicillin-resistant strains and other potential pathogens.

**Why Each Wrong Option is Incorrect**
**Option A:** While penicillin was once a first-line treatment for pneumococcal meningitis, its efficacy has been compromised by the emergence of penicillin-resistant S. pneumoniae strains. Therefore, penicillin is no longer the preferred empirical treatment.

**Option B:** Ciprofloxacin is a fluoroquinolone antibiotic that is effective against a broad range of bacteria. However, its use as empirical treatment for pneumococcal meningitis is not recommended due to the risk of seizures and other central nervous system side effects.

**Option C:** Macrolides, such as azithromycin, may be used as adjunctive therapy in pneumococcal meningitis, but they are not the preferred empirical treatment due to concerns about resistance and efficacy.

**Clinical Pearl / High-Yield Fact**
In cases of suspected bacterial meningitis, empirical treatment should be initiated promptly, and blood cultures should be obtained before starting antibiotics. Vancomycin and a cephalosporin combination provides broad-spectrum coverage, making it an effective empirical treatment for pneumococcal meningitis.

**Correct Answer:** C. Vancomycin